Brief: Camurus Says PDUFA Action Date for Brixadi NDA for Treatment of Opioid Use Disorder In US Set For 23 May 2023
08/12/2022 22:02
Dec 8 (Reuters) - Camurus announces PDUFA date for Brixadi™ NDA for the treatment of opioid use disorder in the US. * Camurus new Prescription Drug User Fee Act (PDUFA) action date is set for 23 May 2023
Recent news on Camurus AB
See all newsBrief: Camurus Receives Approval In Canada For Oczyesa XR
Brief: Executive Sells About £279,000 Of Camurus Shares
Jefferies cuts Ipsen to 'underperform' on Somatuline competition risk
Brief: Camurus Says NDA Resubmission For CAM2029 In Acromegaly Accepted For Review By FDA
Camurus shares rise after Q2 revenue, operating profit beat